Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Can B Corp CANB

Can B Corp. is a health and wellness company. The Company is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The Company is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.


OTCQB:CANB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon Apr 14, 2021 2:41pm
87 Views
Post# 32994091

Can B Corp Strong Gross Margin of 84%

Can B Corp Strong Gross Margin of 84%

https://finance.yahoo.com/news/b-corp-announces-full-2020-100000887.html

Key Recent Highlights:

  • Closed $2.8 million debt financing from an institutional investor, enabling the pay off and elimination of all prior outstanding convertible notes without penalty

  • Tripled production with the installation of new high-speed equipment to expand production at its Pure Health Products facility in Lacey, Washington

  • Raised a total of $4.0 million in equity with ongoing Reg A offering

  • Cash balance of $1.7 million, as of April 2021

Financial Highlights for the Year Ended December 31, 2020 vs. 2019:

  • Gross Profit Increased from 74% in 2019 to 84% in 2020 a 10% Increase

  • Operating Expenses Decreased $1.8 million a 24% Decrease

  • Operating Loss Decreased $1.5 million a 26% Decrease

  • Cash balance of $0.5 million

<< Previous
Bullboard Posts
Next >>